Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesPrompt Responses to the Administration of Ethanol in the Treatment of the Alcohol Withdrawal Syndrome (AWS)
The Neurologist, 09/22/09
Fisher CM – This study suggests the greater use of ethanol in the treatment of AWS. Withdrawal symptoms occurred in subjects who drank only 30 to 60 mL of whiskey daily. Withdrawal manifestations may take up to 10 weeks to clear. The violent reaction of patients to being restrained physically in their management, the restraint reaction, may find its analogy in Watson's intolerable restraint reaction in infants.
Related Articles
Risk factors for delirium tremens in patients with alcohol withdrawal syndrome in a hospital setting
European Journal of Internal Medicine, 10/12/09
Relevance Score: 79%
A new understanding of why seizures occur with alcohol withdrawal
EurekAlert, 10/19/09
Relevance Score: 68%
Moderating effect of emotional intelligence on the role of negative affect in the motivation to drink in alcohol-dependent subjects undergoing protracted withdrawal
Personality and Individual Differences, 11/12/09
Relevance Score: 67%
Increased Acid Sphingomyelinase Activity in Peripheral Blood Cells of Acutely Intoxicated Patients With Alcohol Dependence
Alcoholism, 10/29/09
Relevance Score: 67%
Alcohol control policies and alcohol consumption by youth: a multi-national study
Addiction, 10/19/09
Relevance Score: 47%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology, 12/15/09
An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas
Journal of Pharmacy and Pharmacology, 12/15/09
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/15/09
Today in Neuropsych Sciences...keeping you current
Receive free subspecialty "5-minute updates" via email
The APOE gene and cognitive function in non-demented and Alzheimers disease patients
Reviews in Clinical Gerontology, 12/15/09
Single- and Multiple-Domain Amnestic Mild Cognitive Impairment: Two Sides of the Same Coin
Dementia and Geriatric Cognitive Disorders, 12/15/09
Incidence of Parkinson's Disease in Bulgaria
Neuroepidemiology , 12/15/09
Sponsor
Article Search
Sponsor
Sponsor